BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis

Clinical trial NCT00382629 · COMPLETED

Trial details

NCT number: NCT00382629
Sponsor: Bayhill Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2006-02-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.